Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04510584
Title Maintenance Treatment With Bevacizumab and Atezolizumab for Ovarian Cancer
Recruitment Withdrawn
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors University Health Network, Toronto
Age Groups: adult | senior
Covered Countries CAN

Additional content available in CKB BOOST